Gang Wang

6.0k total citations
143 papers, 4.2k citations indexed

About

Gang Wang is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Gang Wang has authored 143 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Immunology, 60 papers in Oncology and 51 papers in Molecular Biology. Recurrent topics in Gang Wang's work include Immunotherapy and Immune Responses (33 papers), CAR-T cell therapy research (30 papers) and Cancer Immunotherapy and Biomarkers (21 papers). Gang Wang is often cited by papers focused on Immunotherapy and Immune Responses (33 papers), CAR-T cell therapy research (30 papers) and Cancer Immunotherapy and Biomarkers (21 papers). Gang Wang collaborates with scholars based in China, United States and Australia. Gang Wang's co-authors include Patrick Hwu, Huizhong Li, Junnian Zheng, Yanyan Lou, Richard E. Royal, Steven A. Rosenberg, Junnian Zheng, Virginia M. Pickel, Josef Anrather and Costantino Iadecola and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Circulation.

In The Last Decade

Gang Wang

135 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gang Wang China 35 1.8k 1.6k 1.5k 547 361 143 4.2k
Yan Cui China 33 1.2k 0.7× 1.7k 1.0× 1.0k 0.7× 507 0.9× 255 0.7× 126 3.8k
Jian Song China 34 922 0.5× 1.6k 1.0× 555 0.4× 250 0.5× 235 0.7× 163 3.8k
Bo R. Rueda United States 47 1.3k 0.7× 2.7k 1.6× 1.7k 1.1× 570 1.0× 316 0.9× 155 6.5k
David Waugh United Kingdom 33 1.3k 0.7× 2.1k 1.3× 2.0k 1.3× 211 0.4× 672 1.9× 90 5.0k
Qiang Wang China 32 557 0.3× 1.6k 1.0× 939 0.6× 461 0.8× 310 0.9× 151 3.5k
Akira Niwa Japan 31 1.9k 1.1× 1.9k 1.2× 607 0.4× 325 0.6× 189 0.5× 114 4.9k
Xin Yu China 32 2.9k 1.6× 3.5k 2.2× 1.5k 1.0× 622 1.1× 299 0.8× 142 7.9k
Kyoko Nakamura Japan 30 3.3k 1.9× 1.5k 0.9× 1.5k 1.0× 435 0.8× 192 0.5× 107 6.0k
Dimitrios J. Stravopodis Greece 27 1.5k 0.8× 1.9k 1.2× 2.1k 1.4× 375 0.7× 102 0.3× 98 4.7k
Metsada Pasmanik‐Chor Israel 39 895 0.5× 2.3k 1.4× 703 0.5× 437 0.8× 273 0.8× 129 4.5k

Countries citing papers authored by Gang Wang

Since Specialization
Citations

This map shows the geographic impact of Gang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gang Wang more than expected).

Fields of papers citing papers by Gang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gang Wang. The network helps show where Gang Wang may publish in the future.

Co-authorship network of co-authors of Gang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Gang Wang. A scholar is included among the top collaborators of Gang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gang Wang. Gang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Jiaxuan, Kexuan Wang, Qing Wang, et al.. (2025). Hypoxia‐Activated Liposomes Enable Synergistic Photodynamic Therapy for Oral Cancer. Advanced Healthcare Materials. 14(9). e2404395–e2404395. 5 indexed citations
3.
Liu, Xin, Yujun Xu, Xiaoguang Xu, et al.. (2025). Dual cytokine-engineered macrophages rejuvenate the tumor microenvironment and enhance anti-PD-1 therapy in renal cell carcinoma. International Immunopharmacology. 156. 114725–114725. 1 indexed citations
4.
Zhang, Jikai, Chen Zhang, Hang Yin, et al.. (2025). TRIM56 enhances adenoviral E1A steady state to improve oncolytic adenovirus therapy efficacy. Journal of Virology. 99(7). e0004125–e0004125.
5.
Wang, Ruimin, et al.. (2025). Mid-latitude climatic oscillation during the late Ediacaran ice age. Global and Planetary Change. 251. 104823–104823.
6.
Han, Lulu, Yuxin Chen, Nan Huang, et al.. (2024). Cancer-educated neutrophils promote lung cancer progression via PARP-1-ALOX5-mediated MMP-9 expression. Cancer Biology and Medicine. 21(2). 1–18. 7 indexed citations
7.
Zhang, Miaomiao, Haoliang Zhang, Huizhong Li, et al.. (2024). EphA2 specific chimeric antigen receptor engineered T cells for the treatment of prostate cancer. Translational Oncology. 50. 102111–102111. 2 indexed citations
8.
Meng, Jun, et al.. (2024). Indole‐3‐Carboxaldehyde Inhibits Inflammatory Response and Lipid Accumulation in Macrophages Through the miR‐1271‐5p/HDAC9 Pathway. Journal of Cellular and Molecular Medicine. 28(24). e70263–e70263. 4 indexed citations
9.
Tong, Yifan, Mingyu Chen, Zhangfa Song, et al.. (2024). Safety of the stent-based diverting technique after low anterior resection in patients with rectal cancer. 2(3). 100079–100079.
10.
Gao, Ge, Yao‐Wen Jiang, Jiaxuan Chen, et al.. (2024). Three‐in‐One Peptide Prodrug with Targeting, Assembly and Release Properties for Overcoming Bacterium‐Induced Drug Resistance and Potentiating Anti‐Cancer Immune Response. Advanced Materials. 36(23). e2312153–e2312153. 22 indexed citations
11.
Ding, Xiaojuan, et al.. (2023). Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer. Scientific Reports. 13(1). 16244–16244. 6 indexed citations
12.
Zhang, Zhiguo, et al.. (2022). Straightforward synthesis of biologically valuable nonsymmetrical malonamides under mild conditions. Green Chemistry. 24(7). 3035–3041. 12 indexed citations
13.
Li, Xiaokai, Yuxuan Xu, Yuan Yang, et al.. (2021). The Correlation Between UGT1A1 Gene Phenotypes and the Clinical Prognosis of Advanced Colorectal Cancer After FOLFIRI Therapy. Cancer Biotherapy and Radiopharmaceuticals. 36(9). 720–727. 1 indexed citations
14.
Zhang, Huihui, Fanlin Li, Jiang Cao, et al.. (2021). A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity. Science Translational Medicine. 13(578). 77 indexed citations
15.
Wu, Bing, Ge Zhang, Zengli Guo, et al.. (2020). The SKI proto-oncogene restrains the resident CD103+CD8+ T cell response in viral clearance. Cellular and Molecular Immunology. 18(10). 2410–2421. 12 indexed citations
16.
Wang, Gang, et al.. (2019). MiR-451 suppresses the growth, migration, and invasion of prostate cancer cells by targeting macrophage migration inhibitory factor. Translational Cancer Research. 8(2). 647–654. 1 indexed citations
17.
Li, Fugang, Li Liu, Xiaolan Guo, et al.. (2019). Elevated cytokine levels associated with acute kidney injury due to wasp sting. European Cytokine Network. 30(1). 34–38. 17 indexed citations
18.
Yang, Junyao, Ana Moraga, Jing Xu, et al.. (2019). A histone deacetylase 7-derived peptide promotes vascular regeneration via facilitating 14-3-3γ phosphorylation. Stem Cells. 38(4). 556–573. 9 indexed citations
19.
Lou, Yanyan, Chengwen Liu, Grace J. Kim, et al.. (2007). Plasmacytoid Dendritic Cells Synergize with Myeloid Dendritic Cells in the Induction of Antigen-Specific Antitumor Immune Responses. The Journal of Immunology. 178(3). 1534–1541. 112 indexed citations
20.
Wang, Helen Y., Tihui Fu, Gang Wang, et al.. (2002). Induction of CD4+ T cell–dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells. Journal of Clinical Investigation. 109(11). 1463–1470. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026